Meridian Financial Partners LLC Decreases Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Meridian Financial Partners LLC lowered its position in Kenvue Inc. (NYSE:KVUE) by 15.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,218 shares of the company’s stock after selling 5,383 shares during the period. Meridian Financial Partners LLC’s holdings in Kenvue were worth $624,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Huntington National Bank boosted its stake in Kenvue by 26.5% in the third quarter. Huntington National Bank now owns 4,161 shares of the company’s stock valued at $96,000 after acquiring an additional 871 shares in the last quarter. ING Groep NV lifted its holdings in shares of Kenvue by 23.6% during the 3rd quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock valued at $82,727,000 after purchasing an additional 681,954 shares during the last quarter. Saturna Capital Corp boosted its position in shares of Kenvue by 29.9% in the 3rd quarter. Saturna Capital Corp now owns 1,334,860 shares of the company’s stock worth $30,875,000 after purchasing an additional 307,039 shares in the last quarter. Everence Capital Management Inc. boosted its position in shares of Kenvue by 122.1% in the 4th quarter. Everence Capital Management Inc. now owns 45,380 shares of the company’s stock worth $969,000 after purchasing an additional 24,950 shares in the last quarter. Finally, Tyler Stone Wealth Management grew its stake in Kenvue by 134.4% during the 3rd quarter. Tyler Stone Wealth Management now owns 49,050 shares of the company’s stock worth $1,135,000 after buying an additional 28,125 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on KVUE. Deutsche Bank Aktiengesellschaft cut Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Royal Bank of Canada raised shares of Kenvue from a “hold” rating to a “moderate buy” rating in a research report on Monday, December 9th. Barclays upgraded shares of Kenvue to a “hold” rating in a research note on Thursday, December 12th. Bank of America upped their price target on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Finally, Jefferies Financial Group began coverage on shares of Kenvue in a research note on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective for the company. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $23.09.

Kenvue Trading Up 0.4 %

NYSE KVUE opened at $21.06 on Wednesday. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company has a market capitalization of $40.38 billion, a PE ratio of 38.29, a P/E/G ratio of 2.02 and a beta of 1.46. The company has a fifty day moving average of $22.54 and a 200 day moving average of $21.65.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter last year, the business posted $0.31 EPS. The company’s revenue was down .4% on a year-over-year basis. Research analysts forecast that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th were given a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.89%. Kenvue’s dividend payout ratio is presently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.